Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...

RIYADH, Saudi Arabia, Nov. 10, 2024 (GLOBE NEWSWIRE) -- (KFSHRC) announced a significant advancement in stem cell science, ...

▎药明康德内容团队编辑日前，阿斯利康（AstraZeneca）与安进（Amgen）合作开发的“first-in-class”单抗Tezspire（tezepelumab）针对伴有鼻息肉的慢性鼻窦炎（CRSwNP）患者进行的WAYPOINT临床3期试验 ...

As the calendar approaches the middle of November, a lineup of major companies across various sectors is set to report their ...